Search Results - "Ruiz‐Gaspà, Silvia"

Refine Results
  1. 1

    Sclerostin Expression in Bile Ducts of Patients With Chronic Cholestasis May Influence the Bone Disease in Primary Biliary Cirrhosis by Guañabens, Núria, RuizGaspà, Silvia, Gifre, Laia, Miquel, Rosa, Peris, Pilar, Monegal, Ana, Dubrueil, Marta, Arias, Ana, Parés, Albert

    Published in Journal of bone and mineral research (01-09-2016)
    “…ABSTRACT Sclerostin is involved in the regulation of osteoblastogenesis and little is known about its role in the development of bone disease in primary…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Idiopathic Acquired Osteosclerosis in a Middle‐Aged Woman With Systemic Lupus Erythematosus by Guañabens, Núria, Mumm, Steven, Gifre, Laia, RuizGaspà, Silvia, Demertzis, Jennifer L, Stolina, Marina, Novack, Deborah V, Whyte, Michael P

    Published in Journal of bone and mineral research (01-09-2016)
    “…ABSTRACT Widely distributed osteosclerosis is an unusual radiographic finding with multiple causes. A 42‐year‐old premenopausal Spanish woman gradually…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Ursodeoxycholic acid increases differentiation and mineralization and neutralizes the damaging effects of bilirubin on osteoblastic cells by Dubreuil, Marta, Ruiz-Gaspà, Silvia, Guañabens, Nuria, Peris, Pilar, Álvarez, Luisa, Monegal, Ana, Combalia, Andrés, Parés, Albert

    Published in Liver international (01-08-2013)
    “…Background Osteoporosis resulting from decreased bone formation is a common complication in patients with chronic cholestasis. Lithocholic acid (LCA) and…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Bilirubin and bile acids in osteocytes and bone tissue. Potential role in the cholestatic‐induced osteoporosis by RuizGaspà, Silvia, Guañabens, Núria, Jurado, Susana, Combalia, Andreu, Peris, Pilar, Monegal, Ana, Parés, Albert

    Published in Liver international (01-11-2020)
    “…Background and Aims Osteoporosis is a common complication in patients with primary biliary cholangitis. Both bilirubin and lithocholic acid (LCA) result in…”
    Get full text
    Journal Article
  9. 9

    Novel Anti–Hexokinase 1 Antibodies Are Associated With Poor Prognosis in Patients With Primary Biliary Cholangitis by Reig, Anna, Norman, Gary L., Garcia, Mila, Shums, Zakera, Ruiz-Gaspà, Silvia, Bentow, Chelsea, Mahler, Michael, Romera, Maria A., Vinas, Odette, Pares, Albert

    Published in The American journal of gastroenterology (01-10-2020)
    “…Antibodies to hexokinase 1 (HK1) and kelch-like 12 (KLHL12) have been identified as potential biomarkers in primary biliary cholangitis (PBC), and this study…”
    Get full text
    Journal Article
  10. 10

    Bile acids and bilirubin effects on osteoblastic gene profile. Implications in the pathogenesis of osteoporosis in liver diseases by Ruiz-Gaspà, Silvia, Guañabens, Nuria, Jurado, Susana, Dubreuil, Marta, Combalia, Andres, Peris, Pilar, Monegal, Ana, Parés, Albert

    Published in Gene (30-01-2020)
    “…Osteoporosis in advanced cholestatic and end-stage liver disease is related to low bone formation. Previous studies have demonstrated the deleterious…”
    Get full text
    Journal Article
  11. 11
  12. 12

    p38 Regulates Expression of Osteoblast-specific Genes by Phosphorylation of Osterix by Ortuño, María José, Ruiz-Gaspà, Silvia, Rodríguez-Carballo, Edgardo, Susperregui, Antonio R.G., Bartrons, Ramon, Rosa, José Luis, Ventura, Francesc

    Published in The Journal of biological chemistry (15-10-2010)
    “…Osterix, a zinc finger transcription factor, is specifically expressed in osteoblasts and osteocytes of all developing bones. Because no bone formation occurs…”
    Get full text
    Journal Article
  13. 13

    Ursodeoxycholic acid decreases bilirubin-induced osteoblast apoptosis by Ruiz-Gaspà, Silvia, Dubreuil, Marta, Guañabens, Nuria, Combalia, Andrés, Peris, Pilar, Monegal, Ana, Parés, Albert

    Published in European journal of clinical investigation (01-12-2014)
    “…Background Low bone turnover osteoporosis is common in cholestatic diseases. Ursodeoxycholic acid (UDCA) counteracts the damaging effects of bilirubin or…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts by Enjuanes, Anna, Ruiz-Gaspà, Silvia, Peris, Pilar, Ozalla, Dolores, Álvarez, Luisa, Combalia, Andrés, Martínez de Osaba, M. Jesús, Monegal, Ana, Pares, Albert, Guañabens, Nuria

    Published in Endocrine (01-04-2010)
    “…Alendronate is a well-established treatment for osteoporosis and suppresses bone resorption by a direct effect on osteoclasts and their precursors. The effect…”
    Get full text
    Journal Article
  19. 19

    The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts by Enjuanes, Anna, Ruiz-Gaspà, Silvia, Peris, Pilar, Ozalla, Dolores, Álvarez, Luisa, Combalia, Andrés, Martínez de Osaba, M. Jesús, Monegal, Ana, Pares, Albert, Guañabens, Nuria

    Published in Endocrine (01-02-2010)
    “…Alendronate is a well-established treatment for osteoporosis and suppresses bone resorption by a direct effect on osteoclasts and their precursors. The effect…”
    Get full text
    Journal Article
  20. 20

    A new SNP in a negative regulatory region of the CYP19A1 gene is associated with lumbar spine BMD in postmenopausal women by Enjuanes, Anna, Garcia-Giralt, Natalia, Supervía, August, Nogués, Xavier, Ruiz-Gaspà, Silvia, Bustamante, Mariona, Mellibovsky, Leonardo, Grinberg, Daniel, Balcells, Susana, Díez-Pérez, Adolfo

    Published in Bone (New York, N.Y.) (01-05-2006)
    “…Osteoporosis is a common disease of bone possessing a strong genetic component. Cytochrome P450 aromatase, which is encoded by the CYP19A1 gene, converts…”
    Get full text
    Journal Article